AEterna Zentaris (AEZS) BidaskScore is increased to Held

AEterna Zentaris

The BidaskScore of AEterna Zentaris AEZSAEZS shows that the shares of the company are now AEZSStrongly Bought Held by investors.

The BidaskScore of the BiotechnologyBiotechnology shows that the sector is BiotechnologyStrongly Bought Sold since January 4.

Here are the BidAskScore of other related companies in the Biotechnology sector:

Æterna Zentarisˌ Inc. operates as a specialty biopharmaceutical company that is engaged in developing and commercializing novel treatments in oncologyˌ endocrinology and womenʿs health. The companyʿs pipeline encompasses compounds at all stages of developmentˌ from drug discovery through to marketed products. It focuses on the development of Perifosineˌ Cetrotideˌ Ozarelixˌ AEZS-108 and AEZS-130. AEterna Zentaris was founded on September 12ˌ 1990 and is headquartered in Montrealˌ Canada.

AEterna Zentaris

Launched in 2016, the BidAskClubBidaskClub allows users to follow the evolution of the US equity market. BidaskClub provides a platform to create portfolios and be informed when a company´s or sector’s BidaskScore changes. BidaskClub is provided by LuxFinAdviceLuxFinAdvice.